Literature DB >> 16097926

Sustained increase in infectious syphilis notifications in Victoria.

Rebecca J Guy, David E Leslie, Kleete Simpson, Beth Hatch, Jennie Leydon, Margaret E Hellard, Heath A Kelly.   

Abstract

Mesh：

Year:  2005        PMID： 16097926     DOI： 10.5694/j.1326-5377.2005.tb07004.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  5 in total

1.  Development of a real-time PCR assay to detect Treponema pallidum in clinical specimens and assessment of the assay's performance by comparison with serological testing.

Authors:  David E Leslie; Franca Azzato; Theo Karapanagiotidis; Jennie Leydon; Janet Fyfe
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

2.  Opt-out and opt-in testing increases syphilis screening of HIV-positive men who have sex with men in Australia.

Authors:  Rebecca Guy; Carol El-Hayek; Christopher K Fairley; Handan Wand; Andrew Carr; Anna McNulty; Jenny Hoy; Christopher Bourne; John McAllister; B K Tee; David Baker; Norman Roth; Mark Stoove; Marcus Chen
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

3.  A laboratory-based evaluation of four rapid point-of-care tests for syphilis.

Authors:  Louise M Causer; John M Kaldor; Christopher K Fairley; Basil Donovan; Theo Karapanagiotidis; David E Leslie; Peter W Robertson; Anna M McNulty; David Anderson; Handan Wand; Damian P Conway; Ian Denham; Claire Ryan; Rebecca J Guy
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

Review 4.  Looking at the positives: proactive management of STIs in people with HIV.

Authors:  Carole Khaw; Daniel Richardson; Gail Matthews; Tim Read
Journal:  AIDS Res Ther       Date:  2018-12-21       Impact factor: 2.250

5.  A longitudinal evaluation of Treponema pallidum PCR testing in early syphilis.

Authors:  Matt Shields; Rebecca J Guy; Neisha J Jeoffreys; Robert J Finlayson; Basil Donovan
Journal:  BMC Infect Dis       Date:  2012-12-17       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.